Molecular Advances in Central Nervous System Mesenchymal Tumors

Surg Pathol Clin. 2020 Jun;13(2):291-303. doi: 10.1016/j.path.2020.02.002.

Abstract

Mesenchymal tumors of the central nervous system (CNS) comprise an array of neoplasms that may arise from or secondarily affect the CNS and its immediate surroundings. This review focuses on meningiomas and solitary fibrous tumors, the most common primary CNS mesenchymal tumors, and discusses recent advances in unveiling the molecular landscapes of these neoplasms. An effort is made to underscore those molecular findings most relevant to tumor diagnostics and prognostication from a practical perspective. As molecular techniques become more readily used at the clinical level, such alterations may strengthen formal grading schemes and lend themselves to treatment with targeted therapies.

Keywords: Genomics; Hemangioblastoma; Meningioma; Solitary fibrous tumor.

Publication types

  • Review

MeSH terms

  • Brain / pathology
  • Central Nervous System Neoplasms / diagnosis*
  • Central Nervous System Neoplasms / pathology
  • Humans
  • Meningeal Neoplasms / diagnosis
  • Meningeal Neoplasms / pathology
  • Meningioma / diagnosis
  • Meningioma / pathology
  • Prognosis
  • Solitary Fibrous Tumors / diagnosis
  • Solitary Fibrous Tumors / pathology